Virtual Incision cultivate(MD)

cultivate (MD) Capital Funds Portfolio Company Virtual Incision Announces Completion of Clinical Study Enrollment for its MIRA® Platform

Press Release /

FDA decision supported by an interim clinical study report on patient safety Grand Rapids, Mich., February 28, 2023— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Lincoln, Nebraska-based Virtual Incision Corporation, has completed its U.S. Food and Drug […]

cultivate (MD) Capital Funds Portfolio Company Virtual Incision Announces Completion of Clinical Study Enrollment for its MIRA® Platform Read More »

embody cultivate(MD) news

cultivate(MD) Capital Funds Announces Portfolio Company Embody’s Acquisition by Zimmer Biomet Holdings, Inc.

Press Release /

Grand Rapids, Mich., January 10th, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Norfolk, VA-based Embody, Inc., a privately held medical device company focused on soft tissue healing,  has reached an agreement with Zimmer Biomet Holdings, Inc., a global

cultivate(MD) Capital Funds Announces Portfolio Company Embody’s Acquisition by Zimmer Biomet Holdings, Inc. Read More »

HAPPE Spine Announces Andrew Iott as President and CEO

Press Release /

Grand Rapids, Mich., December 7, 2022 — HAPPE Spine announces that Andrew Iott has accepted an offer to become the President and CEO. Mr. Iott brings over twenty years of experience in medical device product development and commercialization, with extensive knowledge of the spine market. As a co-founder of Globus Medical, Mr. Iott played a

HAPPE Spine Announces Andrew Iott as President and CEO Read More »

cultivate(MD) Capital Funds Announces HAPPE Spine’s Additional Patents for Hydroxyapatite Porous Polyetheretherketone Devices

Press Release /

Grand Rapids, Mich., October 5th, 2022— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announces today that one of their portfolio companies, Grand Rapids, MI based HAPPE Spine was granted two more issued patents in a growing portfolio establishing HAPPE as the leader of next generation

cultivate(MD) Capital Funds Announces HAPPE Spine’s Additional Patents for Hydroxyapatite Porous Polyetheretherketone Devices Read More »

SpinTechMRI and Cultivate news and press release

culivate(MD) Capital Funds Announces Lead Participation in Portfolio Company SpinTech MRI’s Series A Financing

Press Release /

Grand Rapids, MI, July 25th, 2022 — Genesis Innovation Group’s cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Bingham Farms, MI based SpinTech MRI announced a $6.5 million Series A financing.

culivate(MD) Capital Funds Announces Lead Participation in Portfolio Company SpinTech MRI’s Series A Financing Read More »

embody cultivate(MD) news

culivate(MD) Capital Funds Announces Portfolio Company Embody, Inc.’s FDA 510(k) Clearance for TAPESTRY® RC Rotator Cuff Repair System

Press Release /

Grand Rapids, MI, June 06, 2022 — Genesis Innovation Group’s cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Norfolk, VA based Embody, Inc. has received FDA 510(k) clearance for theirTAPESTRY® RC System for Rotator Cuff Repair.  

culivate(MD) Capital Funds Announces Portfolio Company Embody, Inc.’s FDA 510(k) Clearance for TAPESTRY® RC Rotator Cuff Repair System Read More »

Virtual Incision robotic surgery ide

Virtual Incision Announces Approval to Complete Clinical Study Enrollment for its MIRA® Platform

Press Release /

FDA decision supported by an interim clinical study report on patient safety Lincoln, Neb. – April 19, 2022 – Virtual Incision Corporation, a medical device company pioneering the world’s first miniaturized robotic-assisted surgery (RAS) platform, today announced the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) supplement to complete the

Virtual Incision Announces Approval to Complete Clinical Study Enrollment for its MIRA® Platform Read More »

Start typing and press enter to search